| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd1424ec65272e6b6118acb3d9aa1b65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d2021eaa0b8fda20dc2907772efdaab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_084eb359fe680ca534c906370d8751f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b1ec9676ebcb8a60c58ef11c9ce05c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c8d185f0676327fd5eb8d7c022b2dfd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f3887b1e0a39daf085b1d83ec1b146e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_808b88cced17e533cf3642d106f3ec02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_894de7e0e3517b719b1e06f1db29bc84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e062446b665ca59549107b9f6ba6222d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ad8ddffe3296ba9945301d5276056d6 |
| publicationDate |
2007-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007058896-A2 |
| titleOfInvention |
Materials and methods for abcb1 polymorphic variant screening, diagnosis, and treatment |
| abstract |
The invention provides methods and materials for screening for polymorphic variants in ABCBl and diagnosing altered susceptibilities for drug-induced heart rhythm irregularities based on the same. These methods allow better treatment regimens for using drugs that bind a protein encoded by the ABCBl and/or induce heart rhythm irregularities such as the anti-cancer drug FK228. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9795650-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108060230-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9624271-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9782451-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9518094-B2 |
| priorityDate |
2005-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |